The pharmacological or nutritional strategy aimed at reducing the activity of cellular pathways that promote the breakdown of complex molecules, such as muscle protein or bone tissue, into simpler components. This process is clinically relevant for preserving lean body mass and bone mineral density, particularly in states of caloric deficit, chronic stress, or aging. Effective suppression shifts the systemic balance toward anabolism, supporting tissue maintenance and repair.
Origin
The term originates from the combination of ‘catabolism,’ derived from the Greek katabole (a throwing down), referring to destructive metabolism, and ‘signaling suppression,’ a concept from molecular biology and pharmacology. It is a specialized term within the study of muscle wasting and metabolic disease. This nomenclature precisely describes the molecular target of interventions designed to combat sarcopenia and frailty.
Mechanism
The primary mechanism involves inhibiting key catabolic mediators, notably the glucocorticoid receptor pathway activated by cortisol, or pathways like the ubiquitin-proteasome system. Targeted compounds may block the transcription factors that initiate the breakdown of structural proteins. By reducing the influence of these destructive signals, the cellular environment favors anabolic processes, allowing for net protein synthesis and tissue retention.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.